Apollomics (APLM) Competitors $6.83 +0.56 (+8.93%) Closing price 03:59 PM EasternExtended Trading$6.82 0.00 (-0.07%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock APLM vs. LIXT, IXHL, CARM, LEXX, CYCC, AIMD, LSB, HOTH, ATNF, and SYBXShould you be buying Apollomics stock or one of its competitors? The main competitors of Apollomics include Lixte Biotechnology (LIXT), Incannex Healthcare (IXHL), Carisma Therapeutics (CARM), Lexaria Bioscience (LEXX), Cyclacel Pharmaceuticals (CYCC), Ainos (AIMD), LakeShore Biopharma (LSB), Hoth Therapeutics (HOTH), 180 Life Sciences (ATNF), and Synlogic (SYBX). These companies are all part of the "pharmaceutical products" industry. Apollomics vs. Its Competitors Lixte Biotechnology Incannex Healthcare Carisma Therapeutics Lexaria Bioscience Cyclacel Pharmaceuticals Ainos LakeShore Biopharma Hoth Therapeutics 180 Life Sciences Synlogic Apollomics (NASDAQ:APLM) and Lixte Biotechnology (NASDAQ:LIXT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations. Does the media prefer APLM or LIXT? In the previous week, Lixte Biotechnology had 3 more articles in the media than Apollomics. MarketBeat recorded 4 mentions for Lixte Biotechnology and 1 mentions for Apollomics. Apollomics' average media sentiment score of 1.91 beat Lixte Biotechnology's score of 0.58 indicating that Apollomics is being referred to more favorably in the media. Company Overall Sentiment Apollomics Very Positive Lixte Biotechnology Positive Which has more risk and volatility, APLM or LIXT? Apollomics has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Lixte Biotechnology has a beta of 0.46, indicating that its stock price is 54% less volatile than the S&P 500. Is APLM or LIXT more profitable? Company Net Margins Return on Equity Return on Assets ApollomicsN/A N/A N/A Lixte Biotechnology N/A N/A -222.90% Do insiders & institutionals believe in APLM or LIXT? 19.1% of Apollomics shares are held by institutional investors. Comparatively, 5.1% of Lixte Biotechnology shares are held by institutional investors. 14.8% of Lixte Biotechnology shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has higher valuation and earnings, APLM or LIXT? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApollomicsN/AN/A-$53.86MN/AN/ALixte BiotechnologyN/AN/A-$3.59M-$1.29-4.66 SummaryApollomics beats Lixte Biotechnology on 4 of the 7 factors compared between the two stocks. Get Apollomics News Delivered to You Automatically Sign up to receive the latest news and ratings for APLM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APLM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APLM vs. The Competition Export to ExcelMetricApollomicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.53M$3.13B$5.79B$10.15BDividend YieldN/A2.32%5.69%4.60%P/E RatioN/A21.3074.5925.92Price / SalesN/A257.21453.5485.33Price / CashN/A45.3337.0859.91Price / Book1.529.6112.156.29Net Income-$53.86M-$53.29M$3.28B$270.77M7 Day Performance32.08%0.28%0.99%3.36%1 Month Performance17.56%8.91%7.21%6.41%1 Year Performance-48.34%13.14%63.07%28.24% Apollomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APLMApollomics0.6564 of 5 stars$6.83+8.9%N/A-55.2%$7.53MN/A0.0045Positive NewsLIXTLixte Biotechnology0.8772 of 5 stars$4.14-7.0%N/A+172.6%$18.88MN/A-3.214Short Interest ↓Gap DownIXHLIncannex Healthcare0.1554 of 5 stars$0.64-3.2%N/A-66.2%$18.78M$98K-0.533Short Interest ↑Gap UpCARMCarisma Therapeutics2.6303 of 5 stars$0.44+104.7%$1.93+337.5%-62.3%$18.39M$19.63M-0.2820Positive NewsShort Interest ↑Gap UpHigh Trading VolumeLEXXLexaria Bioscience3.8953 of 5 stars$0.89+0.6%$4.00+351.5%-69.9%$17.33M$460K-1.327Positive NewsShort Interest ↓CYCCCyclacel Pharmaceuticals0.4419 of 5 stars$7.69-6.6%N/A-97.6%$17.23M$40K-0.0114Short Interest ↑AIMDAinos1.0429 of 5 stars$3.66-4.2%N/A+38.8%$17.06M$20K-0.7340LSBLakeShore Biopharma1.2789 of 5 stars$0.82+2.5%N/A-83.9%$17.03M$85.67M0.00773News CoverageShort Interest ↓Gap DownHOTHHoth Therapeutics2.841 of 5 stars$1.28+10.3%$4.00+212.5%+34.5%$16.97MN/A-1.204Short Interest ↓Gap UpHigh Trading VolumeATNF180 Life Sciences0.1965 of 5 stars$2.81-2.1%N/A+40.3%$16.97MN/A-0.197SYBXSynlogic1.6476 of 5 stars$1.45flatN/A+6.5%$16.97M$10K-18.1380Positive NewsShort Interest ↓Gap Up Related Companies and Tools Related Companies Lixte Biotechnology Competitors Incannex Healthcare Competitors Carisma Therapeutics Competitors Lexaria Bioscience Competitors Cyclacel Pharmaceuticals Competitors Ainos Competitors LakeShore Biopharma Competitors Hoth Therapeutics Competitors 180 Life Sciences Competitors Synlogic Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:APLM) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apollomics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Apollomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLM Stock Alerts